OverviewSuggest Edit

Inari Medical is a medical company developing devices to treat patients suffering from venous diseases. Its product offering consists of two minimally-invasive catheter-based mechanical thrombectomy devices: ClotTriever, a product designed for the removal of a clot from peripheral blood vessels; and FlowTriever, a thrombectomy system for the treatment of pulmonary embolism.

TypePublic
Founded2011
HQIrvine, CA, US
Websiteinarimedical.com
Overall CultureC+

Latest Updates

Employees (est.) (Mar 2020)240
Revenue (FY, 2020)$139.7 M(+174%)
Share Price (Sept 2021)$81
Cybersecurity ratingAMore

Key People/Management at Inari Medical

Bill Hoffman

Bill Hoffman

Chief Executive Officer
Mitch Hill

Mitch Hill

Chief Financial Officer
Tom Tu

Tom Tu

Chief Medical Officer
Drew Hykes

Drew Hykes

Chief Operating Officer
Brian Cox

Brian Cox

Founder
Paul Lubock

Paul Lubock

Co-Founder
Show more

Inari Medical Office Locations

Inari Medical has an office in Irvine
Irvine, CA, US (HQ)
9 Parker #100
Show all (1)

Inari Medical Financials and Metrics

Inari Medical Revenue

Embed Graph
View revenue for all periods
Inari Medical's revenue was reported to be $139.67 m in FY, 2020 which is a 173.2% increase from the previous period.
USD

Revenue (Q2, 2021)

63.5m

Gross profit (Q2, 2021)

58.6m

Gross profit margin (Q2, 2021), %

92.4%

Net income (Q2, 2021)

4.1m

EBIT (Q2, 2021)

4.1m

Market capitalization (16-Sept-2021)

4.0b

Closing stock price (16-Sept-2021)

81.0

Cash (30-Jun-2021)

91.3m

EV

3.9b
Inari Medical's current market capitalization is $4 b.
Annual
USDFY, 2018FY, 2019FY, 2020

Revenue

6.8m51.1m139.7m

Revenue growth, %

649%173%

Cost of goods sold

1.3m5.9m13.1m

Gross profit

5.5m45.2m126.6m
Quarterly
USDQ2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021

Revenue

10.1m14.2m27.0m25.4m38.7m57.4m63.5m

Cost of goods sold

1.3m1.5m2.7m3.5m3.2m4.6m4.8m

Gross profit

8.7m12.7m24.2m21.9m35.5m52.8m58.6m

Gross profit Margin, %

87%89%90%86%92%92%92%
Annual
USDFY, 2019FY, 2020

Cash

23.6m114.2m

Accounts Receivable

11.3m28.0m

Prepaid Expenses

4.0m2.8m

Inventories

464.0k10.6m
Quarterly
USDQ2, 2020Q1, 2021Q2, 2021

Cash

194.8m102.9m91.3m

Accounts Receivable

15.4m31.3m31.5m

Prepaid Expenses

3.9m2.2m2.5m

Inventories

5.6m13.7m18.1m
Annual
USDFY, 2018FY, 2019FY, 2020

Net Income

(10.2m)(1.2m)13.8m

Depreciation and Amortization

283.0k614.0k1.4m

Inventories

(558.0k)(2.9m)(6.6m)

Accounts Payable

372.0k1.8m498.0k
Quarterly
USDQ2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021

Net Income

(1.9m)(1.5m)4.1m308.0k6.8m7.5m11.5m

Depreciation and Amortization

228.0k384.0k274.0k573.0k931.0k609.0k1.3m

Inventories

(1.1m)(2.0m)(1.2m)(1.7m)(3.2m)(3.1m)(7.5m)

Accounts Payable

147.0k1.0m315.0k(255.0k)984.0k2.5m7.3m
USDFY, 2018

Revenue/Employee

222.7k
Show all financial metrics

Inari Medical Operating Metrics

Q1, 2019Q2, 2019Q3, 2019FY, 2019Q1, 2020Q2, 2020Q3, 2020FY, 2020Q1, 2021Q2, 2021

Procedures Performed (DVT Treatment)

3005007002.5 k1.3 k1.4 k2 k5.3 k2.8 k3.1 k

Procedures Performed (PE Treatment)

3004006002.1 k1.1 k1.1 k1.7 k4.1 k2.7 k2.8 k

Procedures Performed

6009001.3 k4.6 k2.4 k2.5 k3.7 k13.2 k5.5 k5.9 k

Clients (Hospitals)

800
Show all operating metrics

Inari Medical Acquisitions / Subsidiaries

Company NameDateDeal Size
Inari Medical Europe GmbH
Inari Medical International, Inc.

Inari Medical Cybersecurity Score

Cybersecurity ratingPremium dataset

A

92/100

SecurityScorecard logo

Inari Medical Online and Social Media Presence

Embed Graph

Inari Medical Company Culture

  • Overall Culture

    C+

    76/100

  • CEO Rating

    A+

    90/100

  • Compensation

    A+

    100/100

Learn more on Comparably

Inari Medical News and Updates

Inari Medical to Present at Upcoming Investor Conferences

IRVINE, Calif., Aug. 26, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, announced today that its management team will presen…

Inari Medical Appoints Outset Medical Executive Rebecca Chambers to Board of Directors

IRVINE, Calif., June 22, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, today announced the appointment of Ms. Rebecca Chambers to its board o…

Inari Medical Announces Late-Breaking CLOUT Registry Data Demonstrating Long-Term Benefits of Lytic-Free Single-Session Near Bloodless Thrombectomy in First 250 Real-World DVT Patients

IRVINE, Calif., June 07, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, today announced strongly positive interim results of the first 250 dee…

Inari Medical to Present at the 2021 Bank of America Healthcare Conference

IRVINE, Calif., April 29, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, announced today that its management team will prese…

Inari Medical Announces Global Partnership with Aidoc to Advance the Timely Detection and Treatment of Pulmonary Embolism

IRVINE, Calif., April 14, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, today announced a new global partnership with Aidoc…

Inari Medical Announces First Patient Enrolled in FLAME Study

IRVINE, Calif., April 05, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, today announced the enrollment of the first high-ri…
Show more

Inari Medical Blogs

Young Professional Recovers Following PE

The post Young Professional Recovers Following PE appeared first on Inari Medical.

New Mother Back with Her Son Following DVT

The post New Mother Back with Her Son Following DVT appeared first on Inari Medical.

Avid Traveler Returns to National Parks

The post Avid Traveler Returns to National Parks appeared first on Inari Medical.

Avid Hiker Back on the Trails after Massive PE with Right Atrium Clot-in-Transit

The post Avid Hiker Back on the Trails after Massive PE with Right Atrium Clot-in-Transit appeared first on Inari Medical.

Heart Strain Fully Resolved After PE

The post Heart Strain Fully Resolved After PE appeared first on Inari Medical.

Retired Teacher Discovers New Outlook on Life

The post Retired Teacher Discovers New Outlook on Life appeared first on Inari Medical.
Show more

Inari Medical Frequently Asked Questions

  • When was Inari Medical founded?

    Inari Medical was founded in 2011.

  • Who are Inari Medical key executives?

    Inari Medical's key executives are Bill Hoffman, Mitch Hill and Tom Tu.

  • How many employees does Inari Medical have?

    Inari Medical has 240 employees.

  • What is Inari Medical revenue?

    Latest Inari Medical annual revenue is $139.7 m.

  • What is Inari Medical revenue per employee?

    Latest Inari Medical revenue per employee is $582 k.

  • Who are Inari Medical competitors?

    Competitors of Inari Medical include Teleflex, AngioDynamics and Penumbra.

  • Where is Inari Medical headquarters?

    Inari Medical headquarters is located at 9 Parker #100, Irvine.

  • Where are Inari Medical offices?

    Inari Medical has an office in Irvine.

  • How many offices does Inari Medical have?

    Inari Medical has 1 office.